CLDN2 and Bartsocas-Papas syndrome 1: Recently, an extensive analysis of gene expression reported a ninety-fold upregulation of Cldn2 mRNA levels in biopsies of patients with IC/BPS, when compared with controls (Sanchez Freire et al., 2010).